28
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Time-to-tumor dose threshold analysis for intratracheal particle instillation-induced lung tumors in a large carcinogenicity study

Pages 278-291 | Published online: 12 Nov 2013
 

Abstract

Background and objectives: A comprehensive time-to-tumor analysis of the 16 dose groups which received intratracheal instillations of “respirable granular bio-durable particles without known significant specific toxicity” (GBP) in a large carcinogenicity study with rats should be conducted.

Methods: The primary lung tumors were mathematically treated as observed in an incidental context (non-fatal occult tumors), based on biological observations and on the fact that lifetime was not considerably reduced even in groups with high tumor frequency. Maximum likelihood estimates of the parameters of time-to-tumor multistage Weibull models were calculated.

Results: Retained dust volume is a highly significantly better dose measure than instilled dust mass, where particle size is taken into account; there is no empirical support for a dose threshold from this study.

Conclusions: Carcinogenicity studies with intratracheal instillation can lead to results that are relevant for the assessment of relative carcinogenic potencies of particles. A dose threshold for GBP is not supported.

For this paper, data were used that were generated in a large animal experiment conducted in the 1990s by F. Pott and M. Roller as employees of the Medical Institute of Environmental Hygiene at the Heinrich-Heine-University, Duesseldorf, Germany. Parts of previous evaluations of the study were supported by the Federal Institute of Occupational Safety and Health (BAuA), Dortmund, Germany.

Disclosure: The author declares no conflict of interest.

The specific analyses for the present paper and the preparation of the manuscript were done by the author (Advisory Office for Risk Assessment) without financial support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.